Sacramento, CA…It seems that unofficially at least the California Dept of Public Health has declared the Covid Pandemic over and the endemic phase of the outbreak underway. From the CDPH guidance…”From January 8, 2022 until February 1, 2022, HCP who test positive for SARS-CoV-2 and are asymptomatic, may return to work immediately without isolation and […]
Sacramento, CA…Governor Gavin Newsom announced that he has activated the California National Guard to support local communities with additional testing facilities and capacity amid the national surge in COVID-19 cases driven by the Omicron variant. “California has led the country’s fight against COVID-19, implementing first-in-the-nation public health measures that have helped save tens of thousands […]
Silver Spring, MD…Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive […]
Cleveland, OH…..A new Cleveland Clinic-led study has identified sildenafil – an FDA-approved therapy for erectile dysfunction (Viagra) and pulmonary hypertension (Revatio) – as a promising drug candidate to help prevent and treat Alzheimer’s disease. According to findings published in Nature Aging, the research team, led by Feixiong Cheng, Ph.D., of Cleveland Clinic’s Genomic Medicine Institute, used computational methodology to […]
New York, NY… Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness. The […]
Atlanta, GA…CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that children 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine. CDC now expands vaccine recommendations to about 28 million children in the United States in this age group and allows providers […]
Sacramento, CA…The Western States Scientific Safety Review Workgroup last night completed its review of the federal process and has unanimously concluded that the Pfizer-BioNTech vaccine is safe and effective for youth 5 to 11 years of age. The Workgroup provided its confirmation to the Governors of California, Nevada, Oregon and Washington this morning. On Friday, […]
Silver Spring, MD….Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who […]
Carson City, NV…Booster recommended for Moderna recipients who are 65 and older, and 18+ recipients who are residing in long-term care facilities, have underlying medical conditions, are at increased risk of social inequities, or who live or work in high-risk settings. Booster recommended for all people 18 and older who received the Johnson & Johnson […]
Kenilworth, NJ…Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine, significantly reduced the risk of hospitalization or death at a planned interim analysis of the Phase 3 MOVe-OUT trial in at risk, non-hospitalized adult patients with mild-to-moderate COVID-19. […]
